430471
Poly(D,L-lactide-co-glycolide)
ester terminated, Mw 50,000-75,000
Synonym(s):
Lactel® B6006-1, PLGA
About This Item
Recommended Products
form
amorphous
feed ratio
lactide:glycolide 85:15
mol wt
Mw 50,000-75,000
degradation timeframe
<6 months
viscosity
0.55-0.75 dL/g, 0.1 % (w/v) in chloroform(25 °C)
transition temp
Tg 45-50 °C
solubility
ethyl acetate, chloroform, acetone and THF: soluble
storage temp.
2-8°C
SMILES string
OCC(O)=O.CC(O)C(O)=O
Looking for similar products? Visit Product Comparison Guide
General description
Application
Features and Benefits
Physical form
Legal Information
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Articles
Interest in utilizing biodegradable polymers for biomedical applications has grown since the 1960s.
Synthetic aliphatic polyesters dominate resorbable biomaterials in clinical use.
AliAliphatic polyesters, including polylactide and polyglycolide, are biodegradable polymers widely used in medical applications.
Immunosuppressive tumor-associated myeloid cells (TAMC) are responsible for glioblastoma (GBM) resistance to immunotherapies and existing standard of care treatments. This mini-review highlights recent progress in implementing nanotechnology in advancing TAMC-targeted therapies for GBM.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service